Momentus Registers 44M Shares for Resale; No New Capital Raised

TL;DR

**Momentus' S-1 is a red flag for dilution, as 44 million shares are hitting the market without the company seeing a dime, signaling potential downward pressure on MNTSW.**

AI Summary

Momentus Inc. (MNTSW) filed an S-1 on October 24, 2025, to register up to 43,989,290 shares of Class A common stock for resale by Selling Stockholders. The company itself is not selling any shares and will not receive any proceeds from these sales. The registered shares include 1,455,746 YP Conversion Shares from a junior secured convertible note, 1,460,964 YP Warrant Shares from warrants issued on September 25, 2025, 40,322,580 ELOC Shares from an equity purchase agreement dated September 25, 2025, and 750,000 YP Pre-Funded Warrant Shares from pre-funded warrants. Momentus, a U.S. commercial space company, focuses on satellite transportation and infrastructure services, including its Vigoride Orbital Service Vehicles (OSVs) and Tape Spring Solar Array (TASSA) technology. The company conducted inaugural test missions with Vigoride in 2022 and two additional missions in 2023. Momentus also entered into a Master Services Agreement with Velo3D, Inc. (VLDX) on April 12, 2025, for additive manufacturing services, securing equivalent capacity of two VLD Sapphire XC 3D metal printers. The last reported sale price of Momentus' Common Stock on October 23, 2025, was $1.28 per share.

Why It Matters

This S-1 filing is crucial for investors as it signals a significant potential dilution event, with up to 43,989,290 shares becoming eligible for resale by existing Selling Stockholders, without Momentus receiving any new capital. For employees and customers, the filing highlights the company's ongoing development in space transportation with Vigoride OSVs and the Velo3D partnership, but the lack of new funding from this specific offering could raise questions about future operational runway. In the competitive space industry, where companies like SpaceX dominate, Momentus' ability to finance its ambitious projects, such as reusable OSVs and TASSA, without direct proceeds from this offering, will be closely watched. The market impact could be negative due to the overhang of a large block of shares potentially entering the market.

Risk Assessment

Risk Level: high — The risk level is high because the S-1 registers 43,989,290 shares for resale by Selling Stockholders, from which Momentus Inc. 'will not receive any proceeds.' This substantial potential influx of shares into the market, coupled with the company's current stock price of $1.28 per share as of October 23, 2025, creates significant dilution risk for existing shareholders and could exert downward pressure on the stock price.

Analyst Insight

Investors should exercise extreme caution and consider the significant dilution risk presented by the 43,989,290 shares registered for resale. Given that Momentus will not receive any proceeds, this offering does not improve the company's financial position. Current shareholders might consider reducing their exposure, while prospective investors should await clearer signs of sustainable revenue growth and a stronger capital structure before initiating a position.

Financial Highlights

debt To Equity

N/A

revenue

$0

operating Margin

N/A

total Assets

$0

total Debt

$0

net Income

$0

eps

$0

gross Margin

N/A

cash Position

$0

revenue Growth

N/A

Key Numbers

• 43,989,290 — Shares of Common Stock (Total shares registered for resale by Selling Stockholders, indicating potential dilution without new capital for Momentus.)
• $1.28 — Stock Price (Last reported sale price of MNTSW on October 23, 2025, providing a baseline for potential resale impact.)
• 1,455,746 — YP Conversion Shares (Shares issuable upon conversion of the junior secured convertible note dated September 25, 2025.)
• 1,460,964 — YP Warrant Shares (Shares issuable upon exercise of warrants issued to Selling Stockholders on September 25, 2025.)
• 40,322,580 — ELOC Shares (Shares issuable to Selling Stockholders pursuant to an equity purchase agreement dated September 25, 2025, representing the largest component of the registered shares.)
• 750,000 — YP Pre-Funded Warrant Shares (Shares issuable upon exercise of pre-funded warrants issued to Selling Stockholders on September 25, 2025.)
• 2022 — Vigoride Inaugural Mission (Year of Momentus' first test and demonstration mission with Vigoride OSV.)
• 2023 — Vigoride Additional Missions (Year of two additional test and demonstration missions with Vigoride OSV.)

Key Players & Entities

• Momentus Inc. (company) — Registrant in S-1 filing
• John C. Rood (person) — Chief Executive Officer of Momentus Inc.
• Lon Ensler (person) — Chief Financial Officer of Momentus Inc.
• Stephen C. Hinton, Esq. (person) — Legal counsel from Bradley Arant Boult Cummings LLP
• Velo3D, Inc. (company) — Partner for additive manufacturing solutions
• SpaceX (company) — Launch service provider partner
• $1.28 (dollar_amount) — Last reported sale price of Common Stock on October 23, 2025
• 43,989,290 (dollar_amount) — Total shares of Common Stock registered for resale
• September 25, 2025 (date) — Date of Yield Point Convertible Note, Warrants, and Equity Purchase Agreement
• April 12, 2025 (date) — Date of Master Services Agreement with Velo3D, Inc.

FAQ

Risk Factors

• Substantial Stockholder Resale Potential [high — financial]: The S-1 registers 43,989,290 shares for resale by existing stockholders. This represents a significant overhang on the stock price, as these shares can be sold into the market without the company receiving any proceeds, potentially depressing the stock price from its current $1.28 level.
• Dependence on Key Technology and Missions [high — operational]: Momentus' success hinges on the reliable performance and scaling of its Vigoride Orbital Service Vehicles (OSVs) and Tape Spring Solar Array (TASSA) technology. While inaugural test missions occurred in 2022 and additional missions in 2023, the company's ability to secure commercial contracts and execute future missions is critical.
• Government Contracts and Approvals [medium — regulatory]: As a U.S. commercial space company, Momentus is subject to various government regulations, export controls, and licensing requirements. Delays or failures in obtaining necessary approvals for its services or technologies could significantly impact its business operations and growth prospects.
• Limited Operating History and Profitability [high — financial]: Momentus is an early-stage company with a limited operating history. The company has not yet demonstrated consistent profitability, and its ability to achieve sustainable revenue growth and positive cash flows from operations remains a key uncertainty.
• Competitive Space Industry Landscape [medium — market]: The commercial space sector is increasingly competitive, with numerous established and emerging players offering satellite transportation and infrastructure services. Momentus faces competition from companies with potentially greater resources and longer track records.
• Equity Purchase Agreement Dilution [high — financial]: The registration of 40,322,580 ELOC Shares from an equity purchase agreement represents the largest portion of the resale shares. This agreement, along with convertible notes and warrants, indicates potential future dilution if these instruments are exercised or converted, impacting existing shareholders.

Industry Context

Momentus operates in the rapidly growing commercial space sector, focusing on satellite transportation and orbital infrastructure. Key trends include the increasing demand for small satellite deployment, in-orbit servicing, and the development of reusable space technologies. The competitive landscape is intensifying with established players and new entrants vying for market share, driven by advancements in launch capabilities and satellite technology.

Regulatory Implications

As a U.S. space technology company, Momentus is subject to stringent regulations from agencies like the FAA and potentially the Department of Defense, covering launch operations, spectrum allocation, and export controls. Compliance with these regulations is critical for operational continuity and market access, and any changes or enforcement actions could pose significant risks.

What Investors Should Do

1. Monitor Selling Stockholder Activity
2. Evaluate Vigoride Mission Success and Commercialization
3. Assess Path to Profitability
4. Understand Dilution Risks

Key Dates

• 2025-09-25: Issuance of Junior Secured Convertible Note, Warrants, and Pre-funded Warrants — These instruments contribute to the large number of shares being registered for resale, indicating potential future dilution and market overhang.
• 2025-09-25: Equity Purchase Agreement — This agreement is the source of the largest block of shares (40,322,580) being registered for resale, highlighting significant potential selling pressure.
• 2025-04-12: Master Services Agreement with Velo3D, Inc. — Secures additive manufacturing capacity, crucial for the production of spacecraft components, indicating strategic partnerships for operational needs.
• 2023-01-01: Two additional Vigoride missions — Demonstrates continued development and testing of Momentus' core satellite transportation technology, building on the 2022 inaugural mission.
• 2022-01-01: Inaugural Vigoride test mission — Marks the first operational demonstration of Momentus' Vigoride Orbital Service Vehicle, a key milestone in its commercialization efforts.
• 2025-10-24: S-1 Filing for Resale of Shares — This filing allows existing stockholders to sell a substantial number of shares, creating immediate market overhang and potential price pressure.

Glossary

S-1 Filing

A registration statement filed with the U.S. Securities and Exchange Commission (SEC) by companies planning to offer securities to the public. It provides detailed information about the company's business, financial condition, and management. (This filing specifically registers shares for resale by existing stockholders, not for raising new capital for Momentus.)

Selling Stockholders

Individuals or entities that own shares of a company's stock and intend to sell them in the public market. (In this S-1, these are the parties who will benefit from selling the registered shares, not Momentus itself.)

Class A Common Stock

A class of common stock typically held by public investors, often with voting rights. (The shares being registered for resale are of this class, impacting the public float and trading dynamics.)

Junior Secured Convertible Note

A debt instrument that can be converted into equity (shares) under certain conditions. 'Junior secured' implies it has a lower priority in repayment compared to senior secured debt. (Conversion of this note results in 1,455,746 YP Conversion Shares being registered for resale.)

Warrants

Financial instruments that give the holder the right, but not the obligation, to buy a company's stock at a specified price (exercise price) before a certain expiration date. (The exercise of these warrants results in 1,460,964 YP Warrant Shares being registered for resale.)

Equity Purchase Agreement

A contract between a seller and a buyer for the purchase of equity (shares) in a company. In this context, it likely involves the issuance of shares to a specific investor. (This agreement is the source of the largest block of shares (40,322,580 ELOC Shares) registered for resale.)

Pre-funded Warrant

A type of warrant that allows the holder to purchase a share for a nominal exercise price, often used to avoid triggering beneficial ownership thresholds or to provide immediate equity-like exposure. (These result in 750,000 YP Pre-Funded Warrant Shares being registered for resale.)

Orbital Service Vehicle (OSV)

A spacecraft designed to provide services in orbit, such as satellite deployment, refueling, or debris removal. (Momentus' Vigoride is an OSV, representing its core product offering in satellite transportation and infrastructure.)

Year-Over-Year Comparison

This S-1 filing focuses on the registration of shares for resale by existing stockholders, rather than a typical financial reporting update. Therefore, a direct comparison of key financial metrics like revenue growth or net income to a previous filing is not applicable. The primary focus is on the potential market overhang created by the 43,989,290 shares eligible for resale, stemming from various financing and warrant agreements executed around September 2025.

Key Financial Figures

• $0.00001 — ares of Class A common stock, par value $0.00001 per share (the "Common Stock"), of Mome
• $1.28 — rted sale price of our Common Stock was $1.28 per share. We are a "smaller reporting
• $3 million — use based on a formula equal to 20% of $3 million less service fees attributed to Momentu
• $2,500,000 — does not show a stockholder's equity of $2,500,000, the Company may again be subject to de

Filing Documents

• ny20047547x40_s1.htm (S-1) — 539KB
• ny20047547x40_ex5-1.htm (EX-5.1) — 9KB
• ny20047547x40_ex23-1.htm (EX-23.1) — 2KB
• ny20047547_ex107.htm (EX-FILING FEES) — 30KB
• logo_momentus.jpg (GRAPHIC) — 37KB
• logo_momentusx1.jpg (GRAPHIC) — 51KB
• ny20047547x40_ex5-1img01.jpg (GRAPHIC) — 321KB
• 0001140361-25-039284.txt ( ) — 1307KB
• ny20047547_ex107_htm.xml (XML) — 14KB

USE OF PROCEEDS

USE OF PROCEEDS 19 SELLING STOCKHOLDER 20 PLAN OF DISTRIBUTION 22 LEGAL MATTERS 24 EXPERTS 25 WHERE YOU CAN FIND MORE INFORMATION 26 INCORPORATION OF CERTAIN INFORMATION BY REFERENCE 27 i TABLE OF CONTENTS ABOUT THIS PROSPECTUS You should rely only on the information contained in this prospectus, as well as the information incorporated by reference into this prospectus and any applicable prospectus supplement. Neither we nor the Selling Stockholders have authorized anyone to provide you with different information. Neither we nor the Selling Stockholders are making an offer of these securities in any jurisdiction where the offer is not permitted. The information contained in this prospectus and any prospectus supplement is accurate only as of the respective dates thereof, and the information in the documents incorporated by reference in this prospectus is accurate only as of the date of those respective documents, regardless of the time of delivery of this prospectus or of any sale of our securities. You should not assume that the information in this prospectus, any applicable prospectus supplement or any documents incorporated by reference is accurate as of any date other than the date of the applicable document. Since the date of this prospectus and the documents incorporated by reference in this prospectus, our business, financial condition, results of operations and prospects may have changed. You should read this prospectus and the related exhibits filed with the SEC, together with the additional information described under the headings " Where You Can Find More Information " and " Incorporation of Certain Information by Reference " before making your investment decision. We are responsible for the information contained in this prospectus. We have not, and the Selling Stockholders have not, authorized anyone to provide you with different information, and we take no, and the Selling Stockholders take no, responsibility for any ot

View Full Filing

View this S-1 filing on SEC EDGAR